Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Bayer Adalat CC

Executive Summary

EXCULPATIONS AND EXPLANATIONS: Bayer Adalat CC: Nifedipine is first-line calcium channel blocker for hypertension, along with Astra Merck's Plendil (felodipine), on Salem, Va. V-A Medical Center formulary, Salem states. "The Pink Sheet" (April 29, T&G-9) erred in reporting Adalat CC had been replaced. Pfizer's Norvasc (amlodipine) was deleted from Salem's formulary in 1995 for cost reasons but was returned in September at the request of cardiologists. The formulary limits Norvasc to patients with coronary artery disease...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS028256

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel